The easy answer is: almost always.
Impact of tinzaparin on cisplatin treatment of tumors with small initial volume.
In addition to all of the above seeking answers to the when, where and how, there is also the question of why.
Use of heparins in patients with cancer: Individual participant data meta-analysis of randomised trials study protocol.